Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Barratt

Showing results (11-20 of 272) with videos related to

Pageof 28
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 6, 2016
Should Immunosuppressive Therapy Be Used in Slowly Progressive IgA Nephropathy?John Feehally, Jonathan Barratt
Kidney International|April 20, 2021
SGLT-2 inhibition in IgA nephropathy: the new standard of care?Jonathan Barratt, Jürgen Floege
Seminars in Nephrology|January 29, 2008
IgA nephropathy: introductionJohn Feehally, Jonathan Barratt
Seminars in Nephrology|August 16, 2011
Primary IgA nephropathy: new insights into pathogenesisJonathan Barratt, John Feehally
Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2024
Dynamic Individualized Risk Prediction in IgA Nephropathy: Entering the Era of Artificial IntelligenceHaresh Selvaskandan, Jonathan Barratt
Seminars in Immunopathology|August 21, 2021
Is IgA nephropathy the same disease in different parts of the world?Hong Zhang, Jonathan Barratt
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 19, 2007
Urine proteomics: the present and future of measuring urinary protein components in diseaseJonathan Barratt, Peter Topham
Kidney360|September 26, 2024
The COVID-19 Vaccination and IgA Nephropathy: Further Cause for ReassuranceHaresh Selvaskandan, Jonathan Barratt
Kidney International|September 27, 2024
The mucosal microbiome and IgA nephropathy: a new target for treatment?Haresh Selvaskandan, Jonathan Barratt
Nature Reviews. Nephrology|October 27, 2009
Glomerular disease: sugars and immune complex formation in IgA nephropathyJonathan Barratt, Frank Eitner
Pageof 28

Showing results (11-20 of 272) with videos related to

Sort By:
Pageof 28
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 6, 2016
Should Immunosuppressive Therapy Be Used in Slowly Progressive IgA Nephropathy?John Feehally, Jonathan Barratt
Kidney International|April 20, 2021
SGLT-2 inhibition in IgA nephropathy: the new standard of care?Jonathan Barratt, Jürgen Floege
Seminars in Nephrology|January 29, 2008
IgA nephropathy: introductionJohn Feehally, Jonathan Barratt
Seminars in Nephrology|August 16, 2011
Primary IgA nephropathy: new insights into pathogenesisJonathan Barratt, John Feehally
Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2024
Dynamic Individualized Risk Prediction in IgA Nephropathy: Entering the Era of Artificial IntelligenceHaresh Selvaskandan, Jonathan Barratt
Seminars in Immunopathology|August 21, 2021
Is IgA nephropathy the same disease in different parts of the world?Hong Zhang, Jonathan Barratt
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 19, 2007
Urine proteomics: the present and future of measuring urinary protein components in diseaseJonathan Barratt, Peter Topham
Kidney360|September 26, 2024
The COVID-19 Vaccination and IgA Nephropathy: Further Cause for ReassuranceHaresh Selvaskandan, Jonathan Barratt
Kidney International|September 27, 2024
The mucosal microbiome and IgA nephropathy: a new target for treatment?Haresh Selvaskandan, Jonathan Barratt
Nature Reviews. Nephrology|October 27, 2009
Glomerular disease: sugars and immune complex formation in IgA nephropathyJonathan Barratt, Frank Eitner
Pageof 28